False Positive Paradox Calculator

Enter a condition's prevalence and a test's sensitivity and specificity to find the true chance that a positive result is real — and how often positives are false when the condition is rare.

Quick Facts

Method
Bayes' theorem: PPV = (Sens×Prev) / (Sens×Prev + (1−Spec)×(1−Prev))
The positive predictive value is the probability a positive test is a true positive.

Your Results

Calculated
Positive predictive value (PPV)
-
Chance a positive result is real
False positive share
-
Positives that are actually false
Negative predictive value (NPV)
-
Chance a negative result is real
Positives per population
-
True vs false positive counts

Ready

Enter prevalence, sensitivity, and specificity, then calculate.

What the false positive paradox is

The false positive paradox is the surprising fact that when a condition is rare, most people who test positive do not actually have the condition — even if the test is very accurate. It is a direct consequence of base rates: a small group of true cases produces only a few true positives, while a much larger healthy group produces enough false positives to outnumber them. The paradox is not a flaw in any particular test; it is a property of applying any imperfect test to a low-prevalence population.

The formula (Bayes' theorem)

The key quantity is the positive predictive value (PPV) — the probability that someone who tests positive truly has the condition. It follows directly from Bayes' theorem:

PPV = (Sensitivity × Prevalence) / (Sensitivity × Prevalence + (1 − Specificity) × (1 − Prevalence))

  • Prevalence — the fraction of the population that actually has the condition (the base rate, or prior probability).
  • Sensitivity — the true positive rate: the probability the test is positive given the person has the condition.
  • Specificity — the true negative rate: the probability the test is negative given the person does not have the condition. Its complement, 1 − specificity, is the false positive rate.

The false positive share among positives is simply 1 − PPV. The mirror-image quantity, the negative predictive value (NPV), is the chance a negative result is truly negative: NPV = (Specificity × (1 − Prevalence)) / (Specificity × (1 − Prevalence) + (1 − Sensitivity) × Prevalence).

The classic worked example

Take a disease that affects 1% of the population, tested with a screen that is 99% sensitive and 99% specific. Imagine 100,000 people. About 1,000 have the disease, and 990 of them test positive (99% sensitivity). The other 99,000 are healthy, but 1% of them — 990 people — also test positive (99% specificity means a 1% false positive rate). So there are 1,980 positives, of which only 990 are real: the PPV is exactly 50%. A positive result is no better than a coin flip, despite a "99% accurate" test. That is the paradox in one calculation.

Common reference points

Holding sensitivity and specificity at 99%, PPV climbs steeply as prevalence rises: it is about 9% at a prevalence of 0.1%, 50% at 1%, roughly 92% at 10%, and about 99% at 50%. Conversely, at a fixed 1% prevalence, raising specificity matters far more than raising sensitivity — improving specificity from 99% to 99.9% lifts the PPV from 50% to about 90%, because it directly shrinks the flood of false positives from the large healthy group.

Frequently Asked Questions

What is the false positive paradox?
It is the counter-intuitive result that when a condition is rare, most positive test results are false positives — even for a highly accurate test. The few true positives from the small affected group are outnumbered by false positives generated from the much larger unaffected group.
How do I calculate the chance a positive result is real?
Use PPV = (sensitivity × prevalence) / (sensitivity × prevalence + (1 − specificity) × (1 − prevalence)), with all three values as fractions between 0 and 1. At 1% prevalence with 99% sensitivity and 99% specificity, PPV = 50%, so half of positives are false.
Why does specificity matter more than sensitivity for rare conditions?
False positives come from the large healthy majority, and specificity controls that rate. When prevalence is low, even a tiny false positive rate applied to a huge group produces more false positives than there are true cases, so small gains in specificity produce large gains in PPV.
How do doctors work around the paradox?
By retesting positives with a second, more specific and independent test. A confirmatory test effectively updates the prevalence to the (much higher) PPV of the first test, which raises the combined PPV dramatically. Screening then confirmation is standard practice for rare-condition testing.